VECTURA

vectura-logo

Vectura Group is a product development company that focuses on the development of pharmaceutical therapies for the treatment of airways-related diseases. This growing market includes asthma and chronic obstructive pulmonary disease (COPD) and is estimated to be worth in excess of $30 billion worldwide.

#SimilarOrganizations #People #Financial #Website #More

VECTURA

Social Links:

Industry:
Health Care Pharmaceutical Wellness

Founded:
1997-01-01

Address:
Chippenham, Wiltshire, United Kingdom

Country:
United Kingdom

Website Url:
http://www.vectura.com

Total Employee:
251+

Status:
Active

Contact:
+4401249667700

Email Addresses:
[email protected]

Total Funding:
14.12 M USD

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving SPF Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Analytics Google Maps Content Delivery Network


Similar Organizations

aerogen-logo

Aerogen

Aerogen is a medical device and drug delivery company.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

altamira-therapeutics-logo

Altamira Therapeutics

Altamira Therapeutics develops novel pharmaceutical therapies to prevent and treat severe inner ear disorders.

biolink-group-logo

Biolink Group

Biolink Group is a life science drug discovery company.

pangenetics-logo

PanGenetics

PanGenetics B.V. develops monoclonal antibodies for the treatment of immune mediated diseases.

not_available_image

Therapeutic Vision

Therapeutic Vision focuses on the development of pharmaceuticals primarily for the companion animal market and eventually their owners.

ultragenyx-pharmaceutical-logo

Ultragenyx Pharmaceutical

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.


Current Advisors List

susan-foden_image

Susan Foden Non-executive Director @ Vectura
Board_member

john-brown_image

John Brown Non-Executive Director and Senior Independent Director @ Vectura
Board_member

bruno-angelici_image

Bruno Angelici Chairman of the Board of Directors @ Vectura
Board_member

Current Employees Featured

trevor-phillips_image

Trevor Phillips
Trevor Phillips COO @ Vectura
COO

karl-keegan_image

Karl Keegan
Karl Keegan Chief Corporate Development Officer @ Vectura
Chief Corporate Development Officer

roger-heerman_image

Roger Heerman
Roger Heerman CCO @ Vectura
CCO

joanne-hombal_image

Joanne Hombal
Joanne Hombal Human Resources Director @ Vectura
Human Resources Director

sharon-johnson_image

Sharon Johnson
Sharon Johnson EVP Delivery Management @ Vectura
EVP Delivery Management
2020-02-01

paul-fry_image

Paul Fry
Paul Fry CFO @ Vectura
CFO
2018-11-01

Stock Details


Company's stock symbol is LSE:VEC

Acquisitions List

Date Company Article Price
2016-03-16 SkyePharma SkyePharma acquired by Vectura 441.3 M GBP
2014-03-13 Activaero Activaero acquired by Vectura 130 M EUR
2006-11-18 Innovata Innovata acquired by Vectura 130 M GBP

Investors List

sitka-partners_image

Sitka Partners

Sitka Partners investment in Private Equity Round - Vectura

isis-capital-management_image

ISIS Capital Management

ISIS Capital Management investment in Private Equity Round - Vectura

excalibur-fund-managers_image

Excalibur Fund Managers

Excalibur Fund Managers investment in Seed Round - Vectura

friends-ivory-sime_image

Friends Ivory & Sime

Friends Ivory & Sime investment in Seed Round - Vectura

Investments List

Date Company Article Money raised
2021-12-29 EnBiotix Vectura investment in Convertible Note - EnBiotix 11 M USD

Official Site Inspections

http://www.vectura.com Semrush global rank: 10.27 M Semrush visits lastest month: 239

  • Host name: ec2-18-133-84-217.eu-west-2.compute.amazonaws.com
  • IP address: 18.133.84.217
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Vectura"

Vectura - Helping you bring inhaled medicines to market

We are a specialist inhalation CDMO that provides innovative inhaled drug development solutions to help customers bring their medicines to patients. See how our scientific innovation and โ€ฆSee details»

Vectura Fertin Pharma

At Vectura Fertin Pharma, we are developing and commercializing a pipeline of differentiated products and brands in wellness and healthcare, driven by innovation and focused on patient and consumer needs.See details»

About Vectura - A leading inhalation specialist CDMO

With more than 20 years of experience in inhalation, Vectura is a world-class specialist CDMO helping you bring inhaled medicines to market.See details»

Vectura - Wikipedia

Vectura Group Limited is a British pharmaceuticals company based in Chippenham, England which develops inhaled medicines and makes inhaler devices. The company was listed on the London Stock Exchange until it was acquired by Philip Morris International in September 2021. See details»

Leadership team - Vectura

Our Board members are committed to a clear, strategic vision for the Group.See details»

Vectura - Crunchbase Company Profile & Funding

Vectura Group is a product development company that focuses on the development of pharmaceutical therapies for the treatment of airways-related diseases. This growing market โ€ฆSee details»

Vectura Group - LinkedIn

Vectura Group | 15,514 followers on LinkedIn. We are a specialist inhalation CDMO helping you bring innovative inhaled medicines to market. | Vectura is a provider of innovative inhaled drug...See details»

About Vectura - pharmiweb.jobs

Apr 24, 2024ย ยท Vectura is a specialist inhalation contract development and manufacturing organization (CDMO) that provides inhaled drug development solutions to help customers โ€ฆSee details»

Vectura Fertin Pharma - Org Chart, Teams, Culture & Jobs - The Org

View Vectura Fertin Pharma's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»

Vectura Group plc - AnnualReports.com

Vectura, a FTSE250 company listed on the London Stock Exchange (LSE: VEC), is an industry-leading device and formulation business for inhaled airways products offering a uniquely integrated inhaled drug delivery platform.See details»

Canadian Lung Association condemns acquisition of Vectura by โ€ฆ

The Canadian Lung Association is sounding the alarm in response to the acquisition of Vectura, a UK based asthma drug maker, by Philip Morris International.See details»

Contact Vectura - Vectura

See how we can help advance your inhaled product development programme. Use this form to get in touch and tell us about you, your project, challenge or area of interest. We look forward โ€ฆSee details»

Vectura Group - Craft

Oct 18, 2021ย ยท Vectura Group has 5 employees across 9 locations and ยฃ190.6 m in annual revenue in FY 2020. See insights on Vectura Group including office locations, competitors, โ€ฆSee details»

Philip Morris seals deal for UK's Vectura despite health group โ€ฆ

Sep 16, 2021ย ยท Vectura's shareholders decided to take the 165 pence-per-share offer from PMI, with nearly 75% backing the deal. Buying the London-listed inhaler maker is part of Philip โ€ฆSee details»

Vectura Group ESG Ambition

Our governance structures support and enable our workforce to give their best and achieve high standards, which, in turn, drives strong business performance. Download our ESG Ambitions โ€ฆSee details»

Vectura Group PLC | Reuters

Sep 15, 2021ย ยท The latest international Vectura Group PLC news and views from Reuters - one of the world's largest news agenciesSee details»

Vectura Group plc | Insights

Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»

Joint statement on the implications of Philip Morris ... - FIRS

Jan 14, 2022ย ยท As health care organizations focused on respiratory health, our missions demand that we actively address those actions which could contribute to an increase in lung disease โ€ฆSee details»

Vectura Group plc Annual Report and Accounts 2020

Jul 10, 2021ย ยท 04 Vectura Group plc Annual Report and Accounts 2020 Despite the challenges of the coronavirus pandemic, we have continued to execute on our inhalation CDMO strategy, โ€ฆSee details»

Home - Vectura Advisory

With a deep understanding of different market regulatory structures and their impacts on incentives for operators, infrastructure providers, investors and governments, Vectura Advisory โ€ฆSee details»

linkstock.net © 2022. All rights reserved